Shanghai InnoPac Medical Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Shanghai InnoPac Medical Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include INTESAFE.
No. 116, Bldg. 10, No. 93 Gongqing Rd.,
Xinbang Village, Songjiang District 201605 Shanghai
Showing of trademarks Trademarks
Trademark Classifications
Shanghai InnoPac Medical Technology Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Shanghai InnoPac Medical Technology Co., Ltd. have?
Shanghai InnoPac Medical Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does Shanghai InnoPac Medical Technology Co., Ltd. file in?
Shanghai InnoPac Medical Technology Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Shanghai InnoPac Medical Technology Co., Ltd.'s most well-known trademarks?
Shanghai InnoPac Medical Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as INTESAFE. These are among 1 currently registered trademark in the portfolio.
What is Shanghai InnoPac Medical Technology Co., Ltd.'s trademark registration success rate?
Shanghai InnoPac Medical Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.